logo
episode-header-image
Jun 2022
28m 5s

Artem Cherkasov and Olexandr Isayev on D...

Nvidia
About this episode
It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a comprehensive, global research review of how deep learning and GPU-accelerated ... Show More
Up next
Jul 9
How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More
31m 40s
Jul 2
Alembic and the Future of AI in Marketing - Ep. 263
Tomás Puig, founder and CEO of Alembic, joins the NVIDIA AI Podcast to discuss the intersection of AI, data, and marketing. He shares how Alembic uses advanced mathematics and AI—particularly spiking neural networks and causal inference—to help brands extract actionable insights ... Show More
39m 44s
Jun 25
Hippocratic AI's Munjal Shah on How AI Agents Are Expanding Healthcare Capacity - Ep. 262
Munjal Shah, CEO of Hippocratic AI, discusses how AI agents can dramatically expand healthcare capacity and access. With 1.8 million patient calls completed and an 8.95/10 satisfaction rating, Hippocratic's safety-focused LLM demonstrates how optimized AI inference can handle rou ... Show More
21m 49s
Recommended Episodes
Feb 2023
Terry Sejnowski: NeurIPS and the Future of AI
In this episode, Terry Sejnowski, an AI pioneer, chairman of the NeurIPS Foundation, and co-creator of Boltzmann Machines, delves into the latest developments in deep learning and their potential impact on our understanding of the human brain. Terry Sejnowski begins by discussing ... Show More
37m 5s
May 2024
Grant Mitchell — The Potential of AI Drug Repurposing
Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing. Grant joins the show to discu ... Show More
1h 5m
Apr 2024
From Theory to Therapy: The Evolution of AI in Medicine with Dr. Daphne Koller
In this episode of the AI Grand Rounds podcast, Dr. Daphne Koller charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued by the capacity of computers for decision-making based on theoreti ... Show More
1h 4m
Apr 2024
The Power of Drug Discovery with Philip Tagari
Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery process as ... Show More
31m 36s
Feb 2024
Moderna and Drug Discovery With AI
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ... Show More
36m 35s
May 2024
What We're Talking About When We Talk About Rural AI
Last October, Dr. Jasmine McNealy, as an associate professor at the University of Florida, a Senior Fellow in Tech Policy with the Mozilla Foundation, and a Faculty Associate at the Berkman Klein Center for Internet & Society at Harvard University, wrote in Tech Policy Press abou ... Show More
42m 20s
Jul 2017
067: Latest Developments in the Field of AI and How it is Changing the World
In this episode of the SuperDataScience Podcast, I chat with Vice President of Research at Sentient AI, Risto Miikkulainen. You will hear about the applications of AI across multiple fields, learn about the 2 types of AI - the Evolutionary Algorithms and Reinforcement Learning Al ... Show More
38m 57s
Jun 2021
Javier Guerrero C., "Narcosubmarines: Outlaw Innovation and Maritime Interdiction in the War on Drugs" (Palgrave, 2020)
Javier Guerrero's "Narcosubmarines: Outlaw Innovation and Maritime Interdiction in the War on Drugs" (Palgrave MacMillan, 2020) is about the encounters of Colombian drug smugglers and the Colombian Navy, both in the open seas and along coastlines. Guerrero specifically examines t ... Show More
38m 30s